Motivational Interviewing: Clinical Trials

40 trials of Motivational Interviewing, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

27 completed, 5 recruiting, 5 unknown, 2 terminated. 40 Phase 2, 6 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 240Completed 27, Recruiting 5, Unknown 5, Terminated 2, Withdrawn 1
Phase 16Completed 2, Unknown 2, Recruiting 1, Terminated 1
Phase 34Completed 3, Withdrawn 1

Follow Motivational Interviewing: new trials by email Literature Review of Motivational Interviewing trials Research Report on Motivational Interviewing

Trials (filtered) newest first · largest first

All 40 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Psilocybin Therapy for Methamphetamine Use Disorder and HIV
Psilocybin 5 mg, Psilocybin 25 mg, Motivational Support - Methamphetamine Use Disorder, Human Immunodeficiency Virus (HIV)
Phase 2RecruitingNicky Mehtani, MD, MPH302026-12-012026-11-09
Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial
IL-22, Prednisone, Acamprosate - Alcohol-associated Hepatitis
Phase 2RecruitingSamer Gawrieh2162026-01-272026-07-15
Motivational Interviewing Intervention For Risky Drinking Treatment Among Indigenous Population
Motivational interviewing - Alcohol Abuse
Phase 1 / Phase 2UnknownDepartment of Public Health Medicine, MARA University of Technology362024-10-012024-09-04
Overcoming Nicotine Dependence to Enable Quitting
Nicotine Replacement Therapy (NRT) Sampling, Practice Quitting (PQ) Counseling, Motivational Interviewing (MI) Counseling - Tobacco Use, Smoking Cessation
Phase 1 / Phase 2RecruitingRush University Medical Center7802023-03-242026-09-09
Vivitrol Treatment for Cannabis Use Disorder
Naltrexone 380 MG [Vivitrol], Motivational Enhancement Therapy and Cognitive Behavioral Therapy - Cannabis Use Disorder
Phase 2TerminatedCentre for Addiction and Mental Health12021-06-092025-02-07
A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol
High-density transcranial alternating current stimulation, Sham stimulation, Motivational interviewing - Alcohol Use Disorder
Phase 2RecruitingThe Mind Research Network752020-09-012025-05-08
Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors
Motivational enhancement therapy, Attention Control - Breast Cancer, Medication Adherence
Phase 2 / Phase 3WithdrawnUniversity of Calgary2020-08-012024-12-05
The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking
CI-581a, CI-581b, MBRP - Alcohol Use Disorder
Phase 2RecruitingNew York State Psychiatric Institute1202019-11-082023-11-07
Peer MI in FQHCs for Substance-using Emerging Adults
Peer-enhanced Motivational Interviewing, Motivational Interviewing, Waitlist Control - Substance Use Disorders
Phase 2UnknownUniversity of Illinois at Urbana-Champaign1502019-08-012018-11-29
Glutamatergic Modulation of Disordered Alcohol Use
CI-581a, CI-581b, Motivational Enhancement Therapy (MET) - Alcohol Dependence
Phase 2 / Phase 3CompletedNew York State Psychiatric Institute502015-07-012020-02-11
Prevention of Drug Use in Adolescence: Intervening in Parenting Styles
Motivational Interviewing for Change of Parenting Styles, Psicoeducation - Substance-Related Disorders
Phase 1 / Phase 2UnknownFederal University of Health Science of Porto Alegre2002014-08-012015-03-11
Improving Adherence to Medication After Coronary Artery Bypass Surgery (CABG) in Older Adults
Motivational Interviewing (MI, volitional intervention, Routine discharge counseling - Coronary Artery Bypass Grafting (CABG) Surgery
Phase 2CompletedQazvin University Of Medical Sciences2882014-03-012023-01-11
Motivational Interviewing to Increase Parent Engagement in Preventive Parenting Programming
Motivational Interviewing, Anticipatory Guidance on Child Development - Behavior Problems, Parent-Child Relations
Phase 2CompletedUniversity of Michigan1122013-09-012015-12-02
Motivational Incentives to Reduce Secondhand Smoke in NICU Infants' Homes
Motivational Interviewing plus Incentives, Conventional Care (CC) - Exposure to Secondhand Smoke in Neonatal Infants
Phase 2CompletedThe University of Texas Health Science Center, Houston3602012-08-012018-05-14
Vet-Harts Pilot Intervention for Veterans With Coronary Heart Disease
Motivational Interview - Heart Disease
Phase 2CompletedVA Office of Research and Development122012-04-302018-12-24
Efficacy Trial of Warrior Check-Up
Motivational Enhancement Therapy, Education - Alcohol Abuse, Alcohol Dependence
Phase 2CompletedUniversity of Washington2422010-10-012015-05-27
Brief Intervention for Problem Drinking and Partner Violence
Motivational Enhancement Therapy - Domestic Violence, Alcohol Abuse
Phase 2CompletedUniversity of Pennsylvania6002010-09-012016-08-22
Brief Intervention to Prevent Poor Psychosocial Outcomes in Living Donors
Motivational Interviewing, Healthy Lifestyles Education - Living Donation
Phase 2CompletedUniversity of Pittsburgh1132010-03-012022-03-02
The Impact of Psychopathic Traits on the Efficacy of a Substance Use Intervention
motivational enhancement therapy, standard care - Substance Use, Psychopathy
Phase 2CompletedUniversity of Rochester1052009-08-012016-12-12
Benefits Counseling to Preserve Function Among Disability Applicants
Benefits Counseling, VA Orientation - Veterans' Disability Claims
Phase 2CompletedVA Office of Research and Development922008-12-012016-03-11

Showing 20 of 40. Sign in to see all of them.

Conditions studied

Substance-Related Disorders (11)  ·  Alcoholism (7)  ·  Marijuana Abuse (3)  ·  Mental Disorders (3)  ·  Smoking (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Diabetes Mellitus (2)  ·  HIV Infections (2)  ·  Obesity (2)  ·  Smoking Cessation (2)  ·  Acute Coronary Syndrome (1)  ·  Alcohol Drinking (1)  ·  Amphetamine-Related Disorders (1)  ·  Antisocial Personality Disorder (1)  ·  Attention Deficit Disorder with Hyperactivity (1)

Sponsors

Medical University of South Carolina (2)  ·  New York State Psychiatric Institute (2)  ·  The University of Texas Health Science Center, Houston (2)  ·  University of Pennsylvania (2)  ·  University of Washington (2)  ·  VA Office of Research and Development (2)  ·  Boston Children's Hospital (1)  ·  Boston Medical Center (1)  ·  Cardiff University (1)  ·  Centre for Addiction and Mental Health (1)  ·  Department of Public Health Medicine, MARA University of Technology (1)  ·  Federal University of Health Science of Porto Alegre (1)  ·  Massachusetts General Hospital (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  National Institute on Drug Abuse (NIDA) (1)

Countries

United States (31)  ·  Canada (2)  ·  Brazil (1)  ·  Iran (1)  ·  Malaysia (1)  ·  Mexico (1)  ·  United Kingdom (1)

Top investigators

Aimee L McRae, PharmD (2)  ·  Elias Dakwar, MD (2)  ·  Adeline Nyamathi, PhD (1)  ·  Amanda Mathew, PhD (1)  ·  Amir H Pakpour, PhD (1)  ·  Angela Stotts, PhD (1)  ·  Bernard Le Foll, MD,PhD,MCFP (1)  ·  Deborah Moss, MD, MPH (1)  ·  Denise D Walker, PhD (1)  ·  Douglas C Smith, PhD (1)  ·  Edmond Wickham, M.D. (1)  ·  Elyse Park, Ph.D. (1)  ·  Hans-Juergen Rumpf, Ph.D. (1)  ·  James R. McKay, Ph.D (1)  ·  Janet Audrain-McGovern, Ph.D (1)

Results publications

PMID 16168872, PMID 16435644, PMID 16443391, PMID 16570748, PMID 16818482, PMID 17063017, PMID 17332036, PMID 17352592, PMID 17518963, PMID 17615014, PMID 17634300, PMID 17682259, PMID 18039285, PMID 18205641, PMID 18254414, PMID 18445798, PMID 18474051, PMID 18594082, PMID 18767507, PMID 19133895, PMID 19186773, PMID 19192101, PMID 19197261, PMID 19329463, PMID 19571052, PMID 20437303, PMID 21512406, PMID 21916925, PMID 21939867, PMID 22891807, PMID 23785451, PMID 23924065, PMID 24090622, PMID 24212451, PMID 24424425, PMID 25082304, PMID 25890676, PMID 26241598, PMID 26727409, PMID 28004259, PMID 29489073, PMID 30126411, PMID 31786934, PMID 31870605, PMID 31894995, PMID 32608505

NIH funding

1DP2DA066200 (1), K23DA015144 (1), K23DA015440 (1), K23DA027720 (1), P30GM122734 (1), P50DA009262 (1), R01AA027509 (1), R01DA013549 (1), R01DA014296 (1), R01DA015690 (1), R01DA023877 (1), R01DK054041 (1), R01HL107404 (1), R03CA130722 (1), R21AA023010 (1)